These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 23208551)
1. Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation. Stasiuk GJ; Smith H; Wylezinska-Arridge M; Tremoleda JL; Trigg W; Luthra SK; Morisson Iveson V; Gavins FN; Long NJ Chem Commun (Camb); 2013 Jan; 49(6):564-6. PubMed ID: 23208551 [TBL] [Abstract][Full Text] [Related]
2. Multimodal formyl peptide receptor 1 targeted inflammation imaging probe: cFLFLF-MHI-DOTA. Li J; Zhang Y; Chordia MD; Wu H; Shao L; Pan D Bioorg Med Chem Lett; 2016 Feb; 26(3):1052-1055. PubMed ID: 26750259 [TBL] [Abstract][Full Text] [Related]
3. MRI visualization of melanoma cells by targeting overexpressed sialic acid with a Gd(III)-dota-en-pba imaging reporter. Geninatti Crich S; Alberti D; Szabo I; Aime S; Djanashvili K Angew Chem Int Ed Engl; 2013 Jan; 52(4):1161-4. PubMed ID: 23225599 [No Abstract] [Full Text] [Related]
4. (99m)Tc SPECT imaging agent based on cFLFLFK for the detection of FPR1 in inflammation. Stasiuk GJ; Holloway PM; Rivas C; Trigg W; Luthra SK; Morisson Iveson V; Gavins FN; Long NJ Dalton Trans; 2015 Mar; 44(11):4986-93. PubMed ID: 25603955 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of a DOTA (Gd3+)-conjugate of proton-pump inhibitor pantoprazole for gastric wall imaging studies. Maharvi GM; Bharucha AE; Fauq AH Bioorg Med Chem Lett; 2013 May; 23(9):2808-11. PubMed ID: 23511016 [TBL] [Abstract][Full Text] [Related]
6. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI. Zhou Z; Wu X; Kresak A; Griswold M; Lu ZR Biomaterials; 2013 Oct; 34(31):7683-93. PubMed ID: 23863450 [TBL] [Abstract][Full Text] [Related]
7. A new bifunctional Gd(III) complex of enhanced efficacy for MR-molecular imaging applications. Tei L; Gugliotta G; Baranyai Z; Botta M Dalton Trans; 2009 Nov; (44):9712-4. PubMed ID: 19885512 [TBL] [Abstract][Full Text] [Related]
8. Gadolinium complexes of monophosphinic acid DOTA derivatives conjugated to cyclodextrin scaffolds: efficient MRI contrast agents for higher magnetic fields. Kotková Z; Helm L; Kotek J; Hermann P; Lukeš I Dalton Trans; 2012 Nov; 41(43):13509-19. PubMed ID: 23018269 [TBL] [Abstract][Full Text] [Related]
9. Zwitterionic Gadolinium(III)-Complexed Dendrimer-Entrapped Gold Nanoparticles for Enhanced Computed Tomography/Magnetic Resonance Imaging of Lung Cancer Metastasis. Liu J; Xiong Z; Zhang J; Peng C; Klajnert-Maculewicz B; Shen M; Shi X ACS Appl Mater Interfaces; 2019 May; 11(17):15212-15221. PubMed ID: 30964632 [TBL] [Abstract][Full Text] [Related]
10. Convenient synthesis of (68)Ga-labeled gadolinium(III) complexes: towards bimodal responsive probes for functional imaging with PET/MRI. Notni J; Hermann P; Dregely I; Wester HJ Chemistry; 2013 Sep; 19(38):12602-6. PubMed ID: 24175335 [TBL] [Abstract][Full Text] [Related]
11. A multiple gadolinium complex decorated fullerene as a highly sensitive T(1) contrast agent. Wang L; Zhu X; Tang X; Wu C; Zhou Z; Sun C; Deng SL; Ai H; Gao J Chem Commun (Camb); 2015 Mar; 51(21):4390-3. PubMed ID: 25676633 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of human glioma cells by means of an interleukin-6 receptor-targeted contrast agent. Sturzu A; Heckl S Chem Biol Drug Des; 2010 Apr; 75(4):369-74. PubMed ID: 20102371 [TBL] [Abstract][Full Text] [Related]
13. Gd3+-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic-2-hydroxypropyl-β-cyclodextrin/Pluronic Polyrotaxane as a Long Circulating High Relaxivity MRI Contrast Agent. Zhou Z; Mondjinou Y; Hyun SH; Kulkarni A; Lu ZR; Thompson DH ACS Appl Mater Interfaces; 2015 Oct; 7(40):22272-6. PubMed ID: 26417911 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, conjugation and relaxation studies of gadolinium(III)-4-benzothiazol-2-yl-phenylamine as a potential brain specific MR contrast agent. Saini N; Varshney R; Tiwari AK; Kaul A; Allard M; Ishar MP; Mishra AK Dalton Trans; 2013 Apr; 42(14):4994-5003. PubMed ID: 23389482 [TBL] [Abstract][Full Text] [Related]
15. Cyclen lanthanide-based micellar structures for application as luminescent [Eu(iii)] and magnetic [Gd(iii)] resonance imaging (MRI) contrast agents. Surender EM; Comby S; Martyn S; Cavanagh B; Lee TC; Brougham DF; Gunnlaugsson T Chem Commun (Camb); 2016 Sep; 52(72):10858-61. PubMed ID: 27523566 [TBL] [Abstract][Full Text] [Related]
16. Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies. Lebdusková P; Hermann P; Helm L; Tóth E; Kotek J; Binnemans K; Rudovský J; Lukes I; Merbach AE Dalton Trans; 2007 Jan; (4):493-501. PubMed ID: 17213936 [TBL] [Abstract][Full Text] [Related]
17. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity. Chen KJ; Wolahan SM; Wang H; Hsu CH; Chang HW; Durazo A; Hwang LP; Garcia MA; Jiang ZK; Wu L; Lin YY; Tseng HR Biomaterials; 2011 Mar; 32(8):2160-5. PubMed ID: 21167594 [TBL] [Abstract][Full Text] [Related]
18. A simple approach to a new T Strauch H; Engelmann J; Scheffler K; Mayer HA Dalton Trans; 2016 Sep; 45(38):15104-15113. PubMed ID: 27711840 [TBL] [Abstract][Full Text] [Related]
19. Multifunctional nanoprobe for MRI/optical dual-modality imaging and radical scavenging. Zhen M; Zheng J; Wang Y; Shu C; Gao F; Zou J; Pyykkö I; Wang C Chemistry; 2013 Oct; 19(43):14675-81. PubMed ID: 24027072 [TBL] [Abstract][Full Text] [Related]
20. Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide. Park JA; Lee YJ; Ko IO; Kim TJ; Chang Y; Lim SM; Kim KM; Kim JY Biochem Biophys Res Commun; 2014 Dec; 455(3-4):246-50. PubMed ID: 25449282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]